OTC · SQIDF
SQI Diagnostics Inc.
$0.01+$0.00 (+14.62%)
SQI Diagnostics Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.67% below the high.
Loading market information…
OTC · CLSH · USD
Stock price, earnings
Quote as of Aug 28, 2025, 12:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
CLS Holdings USA, Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.54% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow CLS Holdings USA, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
CLS Holdings USA, Inc., a diversified cannabis enterprise established in 2014 and headquartered in Miami, Florida, focuses its operations in the United States on extracting and transforming cannabinoids. The company specializes in isolating cannabinoids from cannabis plants and converting them into a variety of concentrates, including oils, waxes, edibles, and shatters. Its comprehensive service and product portfolio includes: Supplying organic medical cannabis to licensed retailers. Providing recreational marijuana products to authorized distributors and retailers. Offering its own in-house derived extraction products, such as oils and waxes. Delivering specialized processing and extraction services for licensed medical cannabis cultivators. Distributing cannabis strains in the form of vegetative cuttings to licensed medical cannabis growers. Providing consulting expertise to various cannabis-related businesses, including cultivators, dispensaries, and laboratories. Performing toll processing services. The company markets its products under the well-known Oasis Cannabis and City Trees brand names, with its concentrates serving pharmaceutical and other purposes.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:17 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2023 |
|---|
| Oct 11, 2023 |
| -$0.01-100.46% vs estimate |
| $100.00-100.0% vs estimate |
| Q4 2022 | Aug 24, 2023 | -$0.05-104.09% vs estimate | $5.58M+44.86% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.01+$0.00 (+14.62%)
SQI Diagnostics Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.67% below the high.
$0.04-$0.00 (-3.31%)
The BC Bud Corporation’s quoted price sits in the lower half of its reported 52-week range, 68.95% below the high.
$0.02+$0.00 (+4.79%)
VIVO Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.5% below the high.
$0.27$0.00 (0.0%)
Qualis Innovations, Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.77% below the high.
$0.12-$0.10 (-44.37%)
Fire & Flower Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 31.43% below the high.
$0.00+$0.00 (+14.94%)
China Infrastructure Construction Corp.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.12+$0.00 (+2.52%)
Acreage Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.06% below the high.
$0.02+$0.00 (+6.19%)
Indiva Limited’s quoted price sits in the upper half of its reported 52-week range, 4.29% below the high.
